Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Cardiology

Understanding GATA6 Syndrome and Pancreatic Agenesis

At a Glance

GATA6 syndrome is a rare genetic developmental disorder that can affect the pancreas, heart, and digestion. Pancreatic underdevelopment may cause diabetes and enzyme deficiency, so care is coordinated across cardiology, endocrinology, gastroenterology, and genetics.

Receiving a diagnosis of a GATA6-related disorder (also known as Pancreatic hypoplasia-diabetes-congenital heart disease syndrome) can feel overwhelming, especially because it is so rare. Neonatal diabetes—diabetes diagnosed within the first six months of life—occurs in roughly 1 in 100,000 to 400,000 births [1]. GATA6 syndrome is a specific genetic subset of these cases, meaning your local doctors may have never encountered it before [2][3].

While the name is complex, the condition is fundamentally a developmental disorder. It occurs because a gene called GATA6, which tells the body how to build the heart, pancreas, and other organs during pregnancy, isn’t working at full strength [4][5]. Because this gene is involved in so many early steps of development, management focuses on supporting each organ system individually rather than a single “cure” for the genetic variant itself [6][7].

The Three Potential Pillars

Management of this condition typically rests on three main pillars. A person may be affected by all three, or only one or two [6].

  1. The Heart (Congenital Heart Disease): In one reported cohort, about 87% of children with a GATA6 mutation had structural heart defects [6], though the absence of a heart defect does not rule out the syndrome. These range from small holes between the heart chambers, like ventricular septal defects (VSD), to more complex “conotruncal” defects where the major arteries of the heart don’t form correctly, such as truncus arteriosus or tetralogy of Fallot [8][9][10].
  2. The Pancreas & Diabetes (Endocrine Function): The pancreas is often smaller than usual (hypoplasia) or missing entirely (agenesis) [1][11]. This results in a lack of insulin-producing cells. While many children develop diabetes in the first few months of life, some may not show signs until childhood or even adulthood [12][10]. In some cases, neonatal diabetes may temporarily go away (remit), but recurrence is possible later in life; its timing cannot be reliably predicted [13][14].
  3. Digestion & Enzymes (Exocrine Function): Because the pancreas is also responsible for making enzymes that digest food, some children have exocrine pancreatic insufficiency (EPI) [13]. Without these enzymes, the body cannot absorb fats or vitamins correctly, leading to poor weight gain, frequent or oily stools, and bloating [7][15].

Why Severity Varies Between Patients

You may find that symptoms look very different from another person with the exact same genetic mutation. This is known as variable expressivity [8][16].

Scientists are still learning why this happens, but even in families where a parent carries the mutation, they may only have a mild heart murmur or adult-onset diabetes, while their child may have more complex heart and pancreatic needs [17][16]. In other cases, the mutation is de novo, meaning it happened for the first time in the child and was not inherited from either parent [6].

Navigating the Diagnosis

Because this syndrome affects multiple systems, care will likely involve a team of specialists including a cardiologist, endocrinologist, and gastroenterologist [3][18][19].

  • Heart Monitoring: Even if a heart defect was repaired or was mild at birth, lesion-specific follow-up with a specialist is standard [20][21].
  • Nutritional Support: If a person has confirmed EPI, doctors typically prescribe pancreatic enzyme replacement therapy (PERT) to help digest food [22][23].
  • Diabetes Technology: Modern tools like continuous glucose monitors (CGM) and insulin pumps are frequently used when indicated to manage blood sugar [24][25].
  • Other Systems: Occasionally, GATA6 can affect other areas, such as the gallbladder or thyroid, which the care team may evaluate based on symptoms [6][12][26].

Management is a marathon, not a sprint, empowering your family with the specialized support needed to thrive at every stage of life [27][28].

Common questions in this guide

What is GATA6 syndrome, and which parts of the body can it affect?
GATA6 syndrome is a rare genetic developmental disorder that can affect how the pancreas, heart, and other organs form before birth. Some people have pancreatic underdevelopment or absence, diabetes, congenital heart defects, digestive enzyme problems, or a combination of these findings.
Does everyone with GATA6 syndrome have a congenital heart defect?
No. Heart defects are common in GATA6 syndrome, but some people have no known heart abnormality or only a mild finding such as a heart murmur. The absence of a heart defect does not rule out the condition, so care teams may still recommend appropriate heart evaluation and follow-up.
Can diabetes caused by GATA6 syndrome go away and come back?
Yes. Diabetes that begins in the newborn period may temporarily improve or go into remission in some people. It can return later in life, and the timing cannot be predicted reliably, so ongoing blood sugar monitoring is important.
What are the signs of exocrine pancreatic insufficiency in GATA6 syndrome?
Exocrine pancreatic insufficiency means the pancreas does not make enough digestive enzymes. Possible signs include poor weight gain, frequent or oily stools, and bloating because the body may not absorb fats and vitamins well; pancreatic enzyme replacement therapy may help when this problem is confirmed.
Which specialists usually care for someone with GATA6 syndrome?
Care commonly involves a cardiologist for heart findings, an endocrinologist for diabetes and blood sugar, and a gastroenterologist for digestion and pancreatic enzyme function. A genetics professional can help explain the GATA6 variant and its family implications, while the specialists coordinate long-term monitoring.
Is GATA6 syndrome inherited from a parent?
A GATA6 variant may be inherited from a parent or may arise for the first time in the child, which is called a de novo variant. The same variant can cause mild findings in one family member and more complex needs in another, so genetic counseling can help assess family risk and testing options.

Get notified when new evidence is published on Pancreatic hypoplasia-diabetes-congenital heart disease syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (28)
  1. 1

    Case report: adult onset diabetes with partial pancreatic agenesis and congenital heart disease due to a de novo GATA6 mutation.

    Sanchez-Lechuga B, Saqlain M, Ng N, et al.

    BMC medical genetics 2020; (21(1)):70 doi:10.1186/s12881-020-01012-2.

    PMID: 32245430
  2. 2

    The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022.

    Rapini N, Delvecchio M, Mucciolo M, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(9)):2349-2357 doi:10.1210/clinem/dgae095.

    PMID: 38408297
  3. 3

    Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.

    Lemelman MB, Letourneau L, Greeley SAW

    Clinics in perinatology 2018; (45(1)):41-59 doi:10.1016/j.clp.2017.10.006.

    PMID: 29406006
  4. 4

    GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.

    Chia CY, Madrigal P, Denil SLIJ, et al.

    Stem cell reports 2019; (12(1)):57-70 doi:10.1016/j.stemcr.2018.12.003.

    PMID: 30629940
  5. 5

    GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm.

    Sharma A, Wasson LK, Willcox JA, et al.

    eLife 2020; (9()).

    PMID: 33054971
  6. 6

    GATA6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum.

    Škorić-Milosavljević D, Tjong FVY, Barc J, et al.

    American journal of medical genetics. Part A 2019; (179(9)):1836-1845 doi:10.1002/ajmg.a.61294.

    PMID: 31301121
  7. 7

    Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion.

    Ito T, Suzuki A, Yamaguchi N, et al.

    Cureus 2025; (17(5)):e83555 doi:10.7759/cureus.83555.

    PMID: 40476119
  8. 8

    Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects.

    Zhang E, Hong N, Chen S, et al.

    Gene 2018; (641()):341-348 doi:10.1016/j.gene.2017.10.083.

    PMID: 29101065
  9. 9

    A NONSENSE GATA6 MUTATION EXPLAINS HISTORY OF CONGENITAL HEART DEFECTS AND 10 YEARS OF POORLY-CONTROLLED DIABETES LACKING DKA IN A NON-OBESE 30 YEAR-OLD INCIDENTALLY FOUND TO HAVE PANCREATIC HYPOPLASIA.

    Miles ML, Cowan N, Jackson G

    AACE clinical case reports 2020; (6(3)):e123-e126 doi:10.4158/ACCR-2019-0156.

    PMID: 32524025
  10. 10

    Novel pathogenic GATA6 variant associated with congenital heart disease, diabetes mellitus and necrotizing enterocolitis.

    Yasuhara J, Manivannan SN, Majumdar U, et al.

    Pediatric research 2024; (95(1)):146-155 doi:10.1038/s41390-023-02811-y.

    PMID: 37700164
  11. 11

    Novel GATA6 mutations in patients with pancreatic agenesis and congenital heart malformations.

    Chao CS, McKnight KD, Cox KL, et al.

    PloS one 2015; (10(2)):e0118449 doi:10.1371/journal.pone.0118449.

    PMID: 25706805
  12. 12

    Monogenic Diabetes with GATA6 Mutations: Characterization of a Novel Family and a Comprehensive Analysis of the GATA6 Clinical and Genetics Traits.

    Yue X, Luo Y, Wang J, Huang D

    Molecular biotechnology 2024; (66(3)):467-474 doi:10.1007/s12033-023-00761-8.

    PMID: 37204622
  13. 13

    The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes.

    Sechko EA, Koltakova MP, Khusainova RI, et al.

    International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252211998.

    PMID: 39596087
  14. 14

    Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience.

    Abali ZY, De Franco E, Karakilic Ozturan E, et al.

    Hormone research in paediatrics 2020; (93(7-8)):423-432 doi:10.1159/000512247.

    PMID: 33498041
  15. 15

    Management of Exocrine Pancreatic Insufficiency in Children.

    Sankararaman S, Schindler T, Sferra TJ

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2019; (34 Suppl 1()):S27-S42 doi:10.1002/ncp.10388.

    PMID: 31535732
  16. 16

    Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities.

    Du YT, Moore L, Poplawski NK, De Sousa SMC

    Endocrinology, diabetes & metabolism case reports 2019; (2019()).

    PMID: 31051468
  17. 17

    A novel GATA6 variant in a boy with neonatal diabetes and diaphragmatic hernia: a familial case with a review of the literature.

    Gaisl O, Konrad D, Joset P, Lang-Muritano M

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(9)):1027-1030.

    PMID: 31271559
  18. 18

    A practical guideline for performing a comprehensive transthoracic echocardiogram in the congenital heart disease patient: consensus recommendations from the British Society of Echocardiography.

    Corbett L, Forster J, Gamlin W, et al.

    Echo research and practice 2022; (9(1)):10 doi:10.1186/s44156-022-00006-5.

    PMID: 36253815
  19. 19

    AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review.

    Whitcomb DC, Buchner AM, Forsmark CE

    Gastroenterology 2023; (165(5)):1292-1301 doi:10.1053/j.gastro.2023.07.007.

    PMID: 37737818
  20. 20

    Consensus recommendations for echocardiography in adults with congenital heart defects from the International Society of Adult Congenital Heart Disease (ISACHD).

    Li W, West C, McGhie J, et al.

    International journal of cardiology 2018; (272()):77-83 doi:10.1016/j.ijcard.2018.07.058.

    PMID: 30017529
  21. 21

    Imaging of congenital heart disease in adults.

    Babu-Narayan SV, Giannakoulas G, Valente AM, et al.

    European heart journal 2016; (37(15)):1182-95 doi:10.1093/eurheartj/ehv519.

    PMID: 26424866
  22. 22

    Exocrine Pancreatic Insufficiency in Children - Challenges in Management.

    Sankararaman S, Schindler T

    Pediatric health, medicine and therapeutics 2023; (14()):361-378 doi:10.2147/PHMT.S402589.

    PMID: 37908317
  23. 23

    Pancreatic Enzyme Replacement Therapy: A Concise Review.

    Brennan GT, Saif MW

    JOP : Journal of the pancreas 2019; (20(5)):121-125.

    PMID: 31736680
  24. 24

    Insulin Delivery Technology for Treatment of Infants with Neonatal Diabetes Mellitus: A Systematic Review.

    Panza R, Cattivera V, Colella J, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2024; (15(11)):2293-2308 doi:10.1007/s13300-024-01653-z.

    PMID: 39292435
  25. 25

    Recent Advances in Neonatal Diabetes.

    Dahl A, Kumar S

    Diabetes, metabolic syndrome and obesity : targets and therapy 2020; (13()):355-364 doi:10.2147/DMSO.S198932.

    PMID: 32104032
  26. 26

    A New Variant in the GATA6 Gene Associated with Tracheoesophageal Fistula, Pulmonary Vein Stenosis, and Neonatal Diabetes.

    Pugnaloni F, Martini L, De Rose DU, et al.

    Hormone research in paediatrics 2025; (98(3)):282-288 doi:10.1159/000536621.

    PMID: 38574486
  27. 27

    Transition and Transfer From Pediatric to Adult Congenital Heart Disease Care in Canada: Call For Strategic Implementation.

    Mackie AS, Fournier A, Swan L, et al.

    The Canadian journal of cardiology 2019; (35(12)):1640-1651 doi:10.1016/j.cjca.2019.08.014.

    PMID: 31813501
  28. 28

    Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association.

    John AS, Jackson JL, Moons P, et al.

    Journal of the American Heart Association 2022; (11(7)):e025278 doi:10.1161/JAHA.122.025278.

    PMID: 35297271

This page is for informational purposes only and does not constitute medical advice about GATA6 syndrome. Your genetics, cardiology, endocrinology, and gastroenterology teams should interpret your results and create an individualized monitoring plan.

Guide contents Pancreatic hypoplasia-diabetes-congenital heart disease syndrome
Research & Literature
02 Genetics, Inheritance, and Biological Diagnosis